pubmed-article:1370091 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0038975 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0039195 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0524637 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0002520 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0003316 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0003343 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0444669 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C1709915 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0443288 | lld:lifeskim |
pubmed-article:1370091 | lifeskim:mentions | umls-concept:C0683941 | lld:lifeskim |
pubmed-article:1370091 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:1370091 | pubmed:dateCreated | 1992-1-17 | lld:pubmed |
pubmed-article:1370091 | pubmed:abstractText | Simian virus 40 (SV40) tumor (T) antigen expressed in H-2b SV40-transformed cells induces the generation of Lyt-2+ (CD8+) cytotoxic T lymphocytes (CTL), which are involved in tumor rejection, in syngeneic mice. Five CTL recognition sites on T antigen have been described by using mutant T antigens. Four of the sites (I, II, III, and V) are H-2Db restricted and have been broadly mapped with synthetic peptides of 15 amino acids in length overlapping by 5 residues at the amino and carboxy termini. The goal of this study was to define the minimal and optimal amino acid sequences of T antigen which would serve as recognition elements for the H-2Db-restricted CTL clones Y-1, Y-2, Y-3, and Y-5, which recognizes sites I, II, III, and V, respectively. The minimal and optimal residues of T antigen recognized by the four CTL clones were determined by using synthetic peptides truncated at the amino or carboxy terminus and an H-2Db peptide-binding motif. The minimal site recognized by CTL clone Y-1 was defined as amino acids 207 to 215 of SV40 T antigen. However, the optimal sequence recognized by CTL clone Y-1 spanned T-antigen amino acids 205 to 215. The T-antigen peptide sequence LT223-231 was the optimal and minimal sequence recognized by both CTL clones Y-2 and Y-3. Site V was determined to be contained within amino acids 489 to 497 of T antigen. The lytic activities of CTL clones Y-2 and Y-3, which recognize a single nonamer peptide, LT223-231, were affected differently by anti-Lyt-2 antibody, suggesting that the T-cell receptors of these two CTL clones differ in their avidities. As the minimal and optimal H-2Db-restricted CTL recognition sites have been defined by nonamer synthetic peptides, it is now possible to search for naturally processed H-2Db-restricted epitopes of T antigen and identify critical residues involved in processing, presentation, and recognition by SV40-specific CTL. | lld:pubmed |
pubmed-article:1370091 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:language | eng | lld:pubmed |
pubmed-article:1370091 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1370091 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1370091 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1370091 | pubmed:month | Jan | lld:pubmed |
pubmed-article:1370091 | pubmed:issn | 0022-538X | lld:pubmed |
pubmed-article:1370091 | pubmed:author | pubmed-author:TevethiaS SSS | lld:pubmed |
pubmed-article:1370091 | pubmed:author | pubmed-author:DeckhutA MAM | lld:pubmed |
pubmed-article:1370091 | pubmed:author | pubmed-author:LippolisJ DJD | lld:pubmed |
pubmed-article:1370091 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1370091 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:1370091 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1370091 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1370091 | pubmed:pagination | 440-7 | lld:pubmed |
pubmed-article:1370091 | pubmed:dateRevised | 2010-9-7 | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:meshHeading | pubmed-meshheading:1370091-... | lld:pubmed |
pubmed-article:1370091 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1370091 | pubmed:articleTitle | Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. | lld:pubmed |
pubmed-article:1370091 | pubmed:affiliation | Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey 17033. | lld:pubmed |
pubmed-article:1370091 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1370091 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:1370091 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1370091 | lld:pubmed |